1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 2: Frequency of adverse events using various contrast media from the literature and our data
Contrast Media Adverse Events Severe Adverse Events
Gadolinium²⁵ 0.8% 0.03%
Iodinated (ionic)²⁶ 12.66% 0.22%
Iodinated (nonionic)²⁶ 3.13% 0.04%
Ferumoxytol (Feraheme label) 3.7% 0.2%
Ferumoxytol (our data) 10.6% 0%

Contrast Media	Adverse Events	Severe Adverse Events
Gadolinium²⁵	0.8%	0.03%
Iodinated (ionic)²⁶	12.66%	0.22%
Iodinated (nonionic)²⁶	3.13%	0.04%
Ferumoxytol (Feraheme label)	3.7%	0.2%
Ferumoxytol (our data)	10.6%	0%